Dan McKay

Dan McKay is the Founder of ReSOLVE and Director of Computation Chemistry at Ventus Therapeutics. Dan has over 24 years of industrial drug discovery experience previously with Novartis and the Merck Frosst Centre for Therapeutic Research. He is co-author of over 45 publications and over 24 patents.

Dan received his BSc in Chemistry and MSc in Theoretical Chemistry from Carleton University in Professor James Wright’s group.